TrialThe oncologist2015

A phase II trial of capecitabine concomitantly with whole-brain radiotherapy followed by capecitabine and sunitinib for brain metastases from breast cancer.

Polly Niravath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.